New Collaborations Sample Clauses
New Collaborations. Through the coordinating efforts of the Joint Management Team and with the benefit of input from subject matter experts, faculty and staff, IU and Purdue will collaborate and cooperate in good faith to identify opportunities and develop plans for new joint endeavors designed to leverage their respective strengths and capabilities in various research programs to drive workforce development, breakthrough discoveries, and the translation and commercialization of innovative solutions to societal challenges. These endeavors may include joint initiatives in, for example: (i) biomedical engineering and health sciences programs; (ii) autonomous and assisted transportation instrumentation, policy and integrity; (iii) cancer detection and therapeutics; and (iv) other types of human and animal drug discovery, among others that may be identified from time to time.
New Collaborations. This Cooperation Agreement shall not in any way ------------------ prohibit either party from collaborating or cooperating with any third party, or from undertaking projects on its own, in any area of endeavor, including but not limited to the Areas of Collaboration; provided, however, that each party shall treat the other as its -------- ------- principal collaborator as set forth in clause 2.1 and consistent therewith shall first offer the other party the opportunity to enter into any collaboration contemplated by such party in the Areas of Collaboration prior to entering into a comparable arrangement with any third party unless such party has a good faith business justification ------ for choosing not to collaborate with the other party on a particular project. In any event, the parties will use good faith efforts to inform each other prior to entering into detailed discussions with third parties about the intent to collaborate or cooperate within the Areas of Collaboration it being the intention that both parties should be free of outside constraints when evaluating the benefit of entering into a joint collaboration or cooperation. Notwithstanding anything in this Cooperation Agreement to the contrary, it is understood and agreed between the parties that nothing in this Cooperation Agreement shall prevent (i) DBI from entering into collaborations or other arrangements with third party pharmaceutical companies in connection with antimicrobial susceptibility testing associated with antimicrobial therapy or (ii) Hoechst from entering into collaborations or other arrangements with third party companies in connection with decentralized near-patient point of care testing and direct pharmaceutical therapy, provided that such third party companies are not in competition with the business of DBI as it exists as of the date hereof.